The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1092
November 13, 2000
View Complete Issue         Table of Contents 2019 
Docosanol Cream (Abreva) for Recurrent Herpes Labialis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Docosanol Cream (Abreva) for Recurrent Herpes Labialis
November 13, 2000 (Issue: 1092)
Doconsanol 10% cream, a long-chain saturated alcohol, has been approved by the FDA for over-the-counter treatment of herpes labialis.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Docosanol Cream (Abreva) for Recurrent Herpes Labialis
Article code: 1092c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.